CLINICAL_TRIALS
trial_result
· 2013-01-09
Clinical Trial Update: Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure [Phase 3]
Summary
A Phase 3 trial evaluating resatorvid in patients with sepsis-induced cardiovascular and respiratory failure was terminated, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Sepsis | Phase 3 | Status: TERMINATED | Results posted: 2013-01-09